The influence of gender-specific factors influencing severe anxiety in psychotic major depression: role of thyroid hormones and depression severity
- PMID: 38693463
- DOI: 10.1007/s00702-024-02781-3
The influence of gender-specific factors influencing severe anxiety in psychotic major depression: role of thyroid hormones and depression severity
Abstract
Background: Psychotic major depression (PMD) is characterized by major depressive disorder (MDD) accompanied by delusions or hallucinations. While the prevalence of PMD and its association with anxiety have been studied, gender-specific differences and the role of thyroid hormones in PMD-related anxiety remain less explored.
Methods: A total of 1718 first-episode and drug-naïve MDD patients was assessed for the presence of PMD and severe anxiety. Clinical assessments, including Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA), Positive and Negative Syndrome Scale (PANSS), and Clinical Global Impressions-Severity (CGI-S) scale, were conducted to assess depression, anxiety, psychotic symptoms, and clinical severity, respectively. Blood samples were collected to measure thyroid function parameters.
Results: The prevalence of severe anxiety was higher in PMD patients compared to non-psychotic MDD patients (71.3% vs. 5.3%). No significant gender differences were observed in the prevalence of severe anxiety among PMD patients. However, elevated thyroid-stimulating hormone (TSH) levels and increased depression severity (HAMD scores) were identified as independent risk factors for severe anxiety in female PMD patients. In contrast, no significant risk factors were found in male PMD patients. The area under the receiver operating characteristic (AUCROC) analysis revealed that the HAMD score and TSH level showed acceptable discriminatory capacity for distinguishing between female PMD patients with and without severe anxiety.
Conclusion: This study highlights the heightened prevalence of severe anxiety in PMD patients, with TSH levels and depression severity emerging as gender-specific risk factors for anxiety in females. These findings suggest the importance of thyroid hormone assessment and tailored interventions for managing anxiety in female PMD patients.
Keywords: Depression severity; Gender differences; Psychotic major depression; Severe anxiety; Thyroid hormones.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Similar articles
-
Prevalence and related factors of anxiety in first episode and drug naïve Chinese Han outpatients with psychotic major depression.J Affect Disord. 2022 Nov 1;316:217-222. doi: 10.1016/j.jad.2022.08.018. Epub 2022 Aug 11. J Affect Disord. 2022. PMID: 35964768
-
Sex Differences in the Prevalence and Correlates of Suicide Attempts in Patients with First-Episode and Drug-Naïve Psychotic Major Depression.Psychopathology. 2025;58(3):199-210. doi: 10.1159/000542844. Epub 2025 Jan 8. Psychopathology. 2025. PMID: 39778539
-
Gender difference in the relationship between clinical symptoms, thyroid hormones, and metabolic parameters in young, first-episode and drug-naïve major depressive disorder patients with suicide attempts: A network analysis perspective.J Psychiatr Res. 2024 Aug;176:411-421. doi: 10.1016/j.jpsychires.2024.06.042. Epub 2024 Jun 28. J Psychiatr Res. 2024. PMID: 38959824
-
Prevalence and risk factors of suicide attempts in young, first-episode and drug-naïve Chinese Han outpatients with psychotic major depressive disorder.Eur Arch Psychiatry Clin Neurosci. 2024 Oct;274(7):1517-1526. doi: 10.1007/s00406-023-01698-4. Epub 2023 Oct 25. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 37878033
-
Association of thyroid dysfunction with suicide attempts in first-episode and drug naïve patients with major depressive disorder.J Affect Disord. 2019 Dec 1;259:180-185. doi: 10.1016/j.jad.2019.08.067. Epub 2019 Aug 20. J Affect Disord. 2019. PMID: 31446378
Cited by
-
Prevalence and related factors of comorbid suicide attempts and psychotic symptoms in first-episode drug-naïve patients with major depressive disorder.BMC Psychiatry. 2025 Jul 29;25(1):733. doi: 10.1186/s12888-025-07186-4. BMC Psychiatry. 2025. PMID: 40730953 Free PMC article.
References
-
- Asadikaram G, Khaleghi E, Sayadi A, Foulady S, Ghasemi MS, Abolhassani M, Nematollahi MH (2019) Assessment of hormonal alterations in major depressive disorder: a clinical study. Psych J 8(4):423–430. https://doi.org/10.1002/pchj.290 - DOI - PubMed
-
- Asvold BO, Vatten LJ, Midthjell K, Bjoro T (2012) Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT study in Norway. J Clin Endocrinol Metab 97(1):93–99. https://doi.org/10.1210/jc.2011-1724 - DOI - PubMed
-
- Benard V, Pignon B, Geoffroy PA, Benradia I, Roelandt JL, Rolland B, Amad A (2020) Depression with and without a history of psychotic symptoms in the general population: sociodemographic and clinical characteristics. J Affect Disord 273:247–251. https://doi.org/10.1016/j.jad.2020.04.048 - DOI - PubMed
-
- Buras A, Battle L, Landers E, Nguyen T, Vasudevan N (2014) Thyroid hormones regulate anxiety in the male mouse. Horm Behav 65(2):88–96. https://doi.org/10.1016/j.yhbeh.2013.11.008 - DOI - PubMed
-
- Chen H, Wang X, Huang Y, Li G, Liu Z, Li Y, Geng H (2019) Prevalence, risk factors and multi-group latent class analysis of lifetime anxiety disorders comorbid depressive symptoms. J Affect Disord 243:360–365. https://doi.org/10.1016/j.jad.2018.09.053 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical